Company Claims New Drug Can Slow Down Alzheimer’s

A sign for biotechnology company Biogen on a building in Cambridge, Mass., on March 18, 2017. Dominick Reuter/AFP/Getty Images

U.S. biotechnology company Biogen announced on Tuesday that it has created the first treatment to effectively slow down Alzheimer’s disease.

The company said it will soon be seeking regulatory approval in the United States for the drug, called aducanumab, and it could be available within two years.